The Middle East Health Journal
SEE OTHER BRANDS

Catch up with healthcare and wellness news from the Middle East

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on April 10, 2025

Lipozem Reviews (Customer Reports): I TRIED IT, Tracked It, and Exposed the Good, Bad & Shocking Truth!

Lipozem Reviews (Customer Reports): I TRIED IT, Tracked It, and Exposed the Good, Bad & Shocking Truth!

LAKELAND, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Lipozem was not even on my radar when I first set out to tackle the stubborn weight that had clung to me for years. I’d dabbled in countless diets—strict low-carb regimens, juice cleanses, punishing …

Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression

Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression

Study uncovers insights about the progression of arthritis, the leading cause of disability which affects 1 in 5 adults and more than half of seniors age 75+ Publication demonstrates a novel therapeutic approach targeting Calnexin that may prevent …

Nextech and Ocuco Announce Strategic Partnership to Revolutionize Optical Solutions

Nextech and Ocuco Announce Strategic Partnership to Revolutionize Optical Solutions

Tampa, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Nextech, a leading technology provider for specialty medical and wellness practices and Ocuco, a global leader in optical software solutions, are excited to announce a strategic partnership to deliver an …

Eleos Expands Executive Leadership Bench Following Series C Fundraise

Eleos Expands Executive Leadership Bench Following Series C Fundraise

BOSTON and TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Eleos, the leader in AI for behavioral health, today announced the appointment of a deep bench of industry-leading executive talent to support the company through its next phase of growth. …

Elixir Medical Announces Launch of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe

Elixir Medical Announces Launch of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe

Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an energy source. IVL technology expands company’s innovative product portfolio. MILPITAS, Calif., …

Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month

Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month

STUDIO CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month, the International Myeloma Foundation (IMF) was truly grateful and overwhelmed by everyone’s support in making the annual campaign a global …

Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.

Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.

Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led development of multiple clinical candidates from conception through IND and early clinical development Vast experience in technology …

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

WASHINGTON, April 10, 2025 (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), will participate in a scientific …

US Ultrasound Market worth US$3.82 billion by 2030 with 7.6% CAGR | MarketsandMarkets™.

US Ultrasound Market worth US$3.82 billion by 2030 with 7.6% CAGR | MarketsandMarkets™.

Delray Beach, FL, April 10, 2025 (GLOBE NEWSWIRE) -- The US Ultrasound Market  is projected to reach US$3.82 billion by 2030 from US$2.46 billion in 2024, at a CAGR of  7.6%. The US ultrasound market is growing due to AI-integrated ultrasound imaging …

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization Market

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization Market

TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion into the rapidly …

TYG Training Launches First Canadian Location in Whitby, Bringing Community-Driven Fitness to Durham Region

TYG Training Launches First Canadian Location in Whitby, Bringing Community-Driven Fitness to Durham Region

WHITBY, Ontario, April 10, 2025 (GLOBE NEWSWIRE) -- TYG Training (TYG) has officially opened its first Canadian location in Whitby at 910 Dundas St W, Unit 104 — a boutique strength and conditioning club designed for all fitness levels and age groups (16 …

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

- Data from the largest retrospective analysis of ENPP1 Deficiency provides insights into the evolution of the disease’s serious cardiovascular and musculoskeletal complications - - Findings highlight the urgent need for early and improved diagnosis, care …

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the “Company”) today announced that its Board of Directors has authorized a share repurchase program under which the …

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel

Latest granted patents reinforce Pluri’s position as a leader in Mucosal-Associated Invariant T (“MAIT”) cell-based cell therapies for solid cancers Pluri’s MAIT platform enables commercial scale production of powerful immune cells as a potential first-in- …

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

VitalHub Announces Recommended Cash Acquisition of Induction Healthcare Group PLC

VitalHub Announces Recommended Cash Acquisition of Induction Healthcare Group PLC

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) is pleased to announce that it has agreed the terms and conditions of a recommended cash acquisition to acquire all of the issued and to be …

Evaxion to present at World Vaccine Congress

Evaxion to present at World Vaccine Congress

Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will give two …

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites …

Avalyn to Participate in Upcoming Investor Conference in April

Avalyn to Participate in Upcoming Investor Conference in April

CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will …

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Guy …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service